Despite severe skin involvement, transcriptional intermediary factor 1 gamma (anti-TIF-1- gamma) is negatively associated with calcinosis.5 The anti-PM-Scl antibody is associated with subcutaneous calcinosis in systemic sclerosis-inflammatory myopathy (IIM) overlap syndrome.5 Here, TRIM33 is linked to calcinosis.